A stress-inducible quorum-sensing peptide mediates the formation of persister cells with noninherited multidrug tolerance

Journal of Bacteriology

Volumn 194, Issue 9, 2012, Pages 2265-2274

  Leung, Vincent ^a   Lévesque, Céline M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CEFOTAXIME; OFLOXACIN; OXACILLIN; RIFAMPICIN; STRESS INDUCIBLE QUORUM SENSING PEPTIDE; UNCLASSIFIED DRUG; VANCOMYCIN;

ARTICLE; BACTERIUM CULTURE; DNA LIBRARY; DRUG TOLERANCE; ENERGY METABOLISM; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUORUM SENSING;

ANTI-BACTERIAL AGENTS; ANTITOXINS; BACTERIAL PROTEINS; BACTERIAL TOXINS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENE LIBRARY; MUTATION; QUORUM SENSING; STREPTOCOCCUS MUTANS;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS MUTANS;

EID: 84861206553     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.06707-11     Document Type: Article

References (55)

1. Alekshun MN, Levy SB. 2007. Molecular mechanisms of antibacterial multidrug resistance. Cell 128:1037-1050.
2. Allison KR, Brynildsen MP, Colins JJ. 2011. Heterogenous bacterial persisters and engineering approaches to eliminate them. Curr. Opin. Microbiol. 14:593-598.
3. Bigger JW. 1944. Treatment of staphylococcal infections with penicillin. Lancet 244:497-500.
4. Biswas I, Jha JK, Fromm N. 2008. Shuttle expression plasmids for genetic studies in Streptococcus mutans. Microbiology 154:2275-2282.
5. Burne RA, Schilling K, Bowen WH, Yasbin RE. 1987. Expression, purification, and characterization of an exo-β-D-fructosidase of Streptococcus mutans. J. Bacteriol. 169:4507- 4517.
6. Buts L, Lah J, Dao-Thi MH, Wyns L, Loris R. 2005. Toxin-antitoxin modules as bacterial metabolic stress managers. Trends Biochem. Sci. 30: 672-679.
7. Claverys JP, Prudhomme M, Martin B. 2006. Induction of competence regulons as a general response to stress in Gram-positive bacteria. Annu. Rev. Microbiol. 60:451- 475.
8. Costerton JW, Stewart PS, Greenberg EP. 2007. Bacterial biofilms: a common cause of persistent infections. Science 284:1318 -1322.
9. Davies D. 2003. Understanding biofilm resistance to antimicrobial agents. Nat. Rev. Drug Discov. 2:114 -122.
10. Davies J, Davies D. 2010. Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 74:417- 433.
11. Defoirdt T, Boon N, Bossier P. 2010. Can. bacteria evolve resistance to quorum sensing disruption? PLoS Pathog. 6:e1000989.
12. del Pozo JL, Patel R. 2007. The challenge of treating biofilm-associated bacterial infections. Clin. Pharmacol. Ther. 82:204 -209.
13. Dörr T, Lewis K, Vulic M. 2009. SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet. 5:e1000760.
14. Dörr T, Vulic M, Lewis K. 2010. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol. 8:e1000317.
15. Dubnau D, Losick R. 2006. Bistability in bacteria. Mol. Microbiol. 61: 564-572.
16. Dufour D, Cordova M, Cvitkovitch DG, Lévesque CM. 2011. Regulation of the competence pathway as a novel role associated with a streptococcal bacteriocin. J. Bacteriol. 193:6552- 6559.
17. Eng RH, Padberg FT, Smith SM, Tan EN, Cherubin CE. 1991. Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob. Agents Chemother. 35:1824 -1828.
18. Fauvart M, De Groote VN, Michiels J. 2011. Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. J. Med. Microbiol. 60:699 -709.
19. Fineran PC, et al. 2009. The phage abortive infection system, ToxIN, functions as a protein-RNA toxin-antitoxin pair. Proc. Natl. Acad. Sci. U. S. A. 106:894-899.
20. Jayaraman R. 2008. Bacterial persistence: some insights into an old phenomenon. J. Biosci. 33:795- 805.
21. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. 2004. Persister cells and and tolerance to antimicrobials. FEMS Microbiol. Lett. 230:13-18.
22. Keren I, Minami S, Rubin E, Lewis K. 2011. Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. mBio 2 (3):e00100 -11. doi:10.1128/mBio.00100-11.
23. Kjos M, et al. 2011. Target recognition, resistance, immunity and genome mining of class II bacteriocins from Gram-positive bacteria. Microbiology 157:3256 -3267.
24. Kolenbrander PE. 2000. Oral microbial communities: biofilms, interactions, and genetic systems. Annu. Rev. Microbiol. 54:413- 437.
25. Korithoski B, Lévesque CM, Cvitkovitch DG. 2008. The involvement of the pyruvate dehydrogenase E1α subunit in Streptococcus mutans acid tolerance. FEMS Microbiol. Lett. 289:13-19.
26. Kreth J, Merritt J, Zhu J, Shi W, Qi F. 2006. Cell-density- and ComEdependent expression of a group of mutacin and mutacin-like genes in Streptococcus mutans. FEMS Microbiol. Lett. 265:11-17.
27. Lau PCY, Sung CK, Lee JH, Morrison DA, Cvitkovitch DG. 2002. PCR ligation mutagenesis in transformable streptococci: application and efficiency. J. Microbiol. Methods 49:193-205.
28. Lévesque CM, et al. 2005. Involvement of sortase anchoring of cell wall proteins in biofilm formation by Streptococcus mutans. Infect. Immun. 73:3773-3777.
29. Lewis K. 2007. Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 5:48 -56.
30. Lewis K. 2008. Multidrug tolerance of biofilms and persister cell. Curr. Top. Microbiol. Immunol. 322:107-131.
31. Lewis K. 2010. Persister cells. Annu. Rev. Microbiol. 64:357-372.
32. Li YH, Hanna MN, Svensäter G, Ellen RP, Cvitkovitch DG. 2001. Cell density modulates acid adaptation in Streptococcus mutans: implications for survival in biofilms. J. Bacteriol. 183:6875- 6884.
33. Maisonneuve E, Shakespeare LJ, Jørgensen MG, Gerdes K. 2011. Bacterial persistence by RNA endonucleases. Proc. Natl. Acad. Sci. U. S. A. 108:13206 -13211.
34. Makarova KS, Wolf YI, Koonin EV. 2009. Comprehensive comparativegenomic analysis of type 2 toxin-antitoxin systems and related mobile stress response systems in prokaryotes. Biol. Direct. 4:19.
35. Marsh PD. 2005. Dental plaque: biological significance of a biofilm and community lifestyle. J. Clin. Periodontol. 32:7-15.
36. Marsh PD. 2006. Dental plaque as a biofilm and a microbial community: implications for health and disease. BMC Oral Health 6:S14.
37. Möker N, Dean CR, Tao J. 2010. Pseudomonas aeruginosa increases formation of multidrug tolerance persister cells in response to quorum sensing signaling molecules. J. Bacteriol. 192:1946 -1955.
38. Moyed HS, Bertrand KP. 1983. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J. Bacteriol. 155:768 -775.
39. Oggioni MR, Morrison DA. 2008. Cooperative regulation of competence development in Streptococcus pneumoniae: cell-to-cell signaling via a peptide pheromone and an alternative sigma factor, p 345-362. In Winans SC, Bassler BL (ed), Chemical communication among bacteria. ASM Press, Washington, DC.
40. Parsek MR, Greenberg EP. 2005. Sociomicrobiology: the connection between quorum sensing and biofilms. Trends Microbiol. 13:27-33.
41. Perry JA, Jones MB, Peterson SN, Cvitkovitch DG, Lévesque CM. 2009. Peptide alarmone signaling triggers an auto-active bacteriocin necessary for genetic competence. Mol. Microbiol. 72:905-917.
42. Platt TG, Fuqua C. 2010. What's in a name? The semantics of quorum sensing. Trends Microbiol. 18:383-387.
43. Prudhomme M, Attaiech L, Sanchez G, Martin B, Claverys JP. 2006. Antibiotic stress induces genetic transformability in the human pathogen Streptococcus pneumoniae. Science 313:89 -92.
44. Shah D, Zhang Z, Khodursky A, Kaldalu N, Kurg K, et al. 2006. Persisters: a distinct physiological state of Escherichia coli.BMC Microbiol. 6:53.
45. Spoering AL, Vulic M, Lewis K. 2006. GlpD and PlsB participate in persister cell formation in Escherichia coli. J. Bacteriol. 188:5136 -5144.
46. Suntharalingam P, Senadheera MD, Mair RW, Lévesque CM, Cvitkovitch DG. 2009. The LiasFSR system regulates the cell envelope stress response in Streptococcus mutans. J. Bacteriol. 191:2973-2984.
47. Syed MA, et al. 2011. The chromosomal mazEF locus of Streptococcus mutans encodes a functional type II toxin-antitoxin addiction system. J. Bacteriol. 193:1122-1130.
48. Van der Ploeg JR. 2005. Regulation of bacteriocin production in Streptococcus mutans by the quorum-sensing system required for development of genetic competence. J. Bacteriol. 187:3980 -3989.
49. Van Melderen L. 2010. Toxin-antitoxin systems: why so many, what for? Curr. Opin. Microbiol. 13:781-785.
50. Veening JW, Smits WK, Kuipers OP. 2008. Bistability, epigenetics, and bet-hedging in bacteria. Annu. Rev. Microbiol. 62:193-210.
51. Wang B, Kuramitsu HK. 2003. Control of enzyme IIscr and sucrose-6-phosphate hydrolase activities in Streptococcus mutans by transcriptional repressor ScrR binding to the cis-active determinants of the scr regulon. J. Bacteriol. 185:5791-5799.
52. Wang X, Wood TK. 2011. Toxin-antitoxin systems influence biofilm and persister cell formation and the general stress response. Appl. Environ. Microbiol. 77:5577-5583.
53. Wiuff C, et al. 2005. Phenotypic tolerance: antibiotic enrichment on noninherited resistance in bacterial populations. Antimicrob. Agents Chemother. 49:1483-1494.
54. Yamaguchi Y, Park JH, Inouye M. 2011. Toxin-antitoxin systems in bacteria and archae. Annu. Rev. Genet. 45:61-79.
55. Zaura E, Keijser BJF, Huse SM, Crielaard W. 2009. Defining the healthy "core microbiome" of oral microbial communities. BMC Microbiol. 9:259.